Prasterone - Jenapharm

Drug Profile

Prasterone - Jenapharm

Alternative Names: Dehydroepiandrosterone - Jenapharm; DHEA - Jenapharm

Latest Information Update: 15 Jan 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Jenapharm
  • Class Androstenols; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Protein synthesis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Adrenal insufficiency; Hypogonadism; Menopausal syndrome

Most Recent Events

  • 13 Feb 2006 No development reported - Clinical-Phase-Unknown for Adrenal insufficiency in Germany (PO)
  • 13 Feb 2006 No development reported - Clinical-Phase-Unknown for Hypogonadism in Germany (PO)
  • 13 Feb 2006 No development reported - Clinical-Phase-Unknown for Menopausal syndrome in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top